Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
January-2018 Volume 17 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2018 Volume 17 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Dysifragilone A inhibits LPS‑induced RAW264.7 macrophage activation by blocking the p38 MAPK signaling pathway

  • Authors:
    • Huixiang Li
    • Qian Zhang
    • Xin Jin
    • Xiaowen Zou
    • Yuexuan Wang
    • Dexiang Hao
    • Fenghua Fu
    • Weihua Jiao
    • Cuixia Zhang
    • Houwen Lin
    • Keiichi Matsuzaki
    • Feng Zhao
  • View Affiliations / Copyright

    Affiliations: Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, School of Pharmacy, Yantai University, Yantai, Shandong 264005, P.R. China, Research Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China, Pharmaceutical Preparation Section, Xing Fu Hospital of Zhi Fu, Yantai, Shandong 264000, P.R. China, School of Pharmacy, Nihon University, Narashinodai, Funabashi, Chiba 274‑8555, Japan
  • Pages: 674-682
    |
    Published online on: October 26, 2017
       https://doi.org/10.3892/mmr.2017.7884
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Dysifragilone A, a sesquiterpene aminoquinone based on a rearranged avarone skeleton, has been previously isolated and identified from the South China Sea sponge Dysidea fragilis. In the present study, anti‑inflammatory activity and the underlying molecular mechanism of dysifragilone A were studied using the classical inflammation model of lipopolysaccharide (LPS)‑activated RAW264.7 macrophage cells and an MTT assay, Griess method, ELISA and western blotting were used. The results revealed that dysifragilone A significantly reduced the release of inflammatory mediators and inflammatory cytokines in activated RAW264.7 cells, including nitric oxide (NO), prostaglandin E2,(PGE2) and interleukin‑6 (IL‑6). The protein expression levels of inducible nitric oxide synthase (iNOS), cyclooxygenase‑2 (COX‑2), and the enzymatic activity of iNOS and COX‑2 were also inhibited by dysifragilone A in a dose dependent manner. Further mechanistic investigations suggested that the anti‑inflammatory activity of dysifragilone A results from the suppression of p38 mitogen‑activated protein kinase (MAPK) activation in LPS‑activated macrophages; however, this was not associated with inhibition of the extracellular signal‑regulated kinase (ERK) or c‑Jun N‑terminal kinase (JNK) signaling pathways. Therefore, dysifragilone A and similar compounds may be anti‑inflammatories that have potential to be used in the clinic.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Bell JJ: The functional roles of marine sponges. Estuar Coast Shelf S. 79:341–353. 2008. View Article : Google Scholar

2 

Braekman JC and Daloze D: Chemical and biological aspects of sponge secondary metabolites. Phytochem Rev. 3:275–283. 2004. View Article : Google Scholar

3 

Hooper JNA and Van Soest RWM: Systema porifera: A guide to the classification of sponges. New York: Kluwer Plenum; pp. 1–7. 2002, View Article : Google Scholar

4 

Gerwick WH and Moore BS: Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. Chem Biol. 19:85–98. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Salomon CE, Williams DH and Faulkner DJ: New azacyclopropene derivatives from Dysidea fragilis collected in Pohnpei. J Nat Prod. 58:1463–1466. 1995. View Article : Google Scholar : PubMed/NCBI

6 

Su JY, Zhong YL, Zeng LM, Wei S, Wang QW, Mak TCW and Zhou ZY: Three new diketopiperazines from a marine sponge Dysidea fragilis. J Nat Prod. 56:637–642. 1993. View Article : Google Scholar

7 

Fu X, Zeng LM, Su JY and Pais M: A new diketopiperazine derivative from the South China Sea sponge Dysidea fragilis. J Nat Prod. 60:695–696. 1997. View Article : Google Scholar

8 

Milkova TS, Mikhova BP, Nikolov NM, Popov SS and Andreev SN: Two new polyhydroxylated sterols from the sponge Dysidea fragilis. J Nat Prod. 55:974–978. 1992. View Article : Google Scholar

9 

Guella G, Guerriero A and Pietra F: Sesquiterpenoids of the sponge Dysidea fragilis of the North-Brittany Sea. Helv Chim Acta. 68:39–48. 1985. View Article : Google Scholar

10 

Utkina NK, Kazantseva MV and Denisenko V: Brominated diphenyl ethers from the marine sponge Dysidea fragilis. Chem Nat Compd. 23:508–509. 1987. View Article : Google Scholar

11 

Jiao WH, Huang XJ, Yang JS, Yang F, Piao SJ, Gao H, Li J, Ye WC, Yao XS, Chen WS and Lin HW: Dysidavarones A-D, new sesquiterpene quinones from the marine sponge Dysidea avara. Org Lett. 14:202–205. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Jiao WH, Xu TT, Yu HB, Chen GD, Huang XJ, Yang F, Li YS, Han BN, Liu XY and Lin HW: Dysideanones A-C, unusual sesquiterpene quinones from the South China Sea sponge Dysidea avara. J Nat Prod. 77:346–350. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Jiao WH, Xu TT, Yu HB, Mu FR, Li J, Li YS, Yang F, Han BN and Lin HW: Dysidaminones A-M, cytotoxic and NF-κB inhibitory sesquiterpene aminoquinones from the South China Sea sponge Dysidea fragilis. RSC Adv. 4:9236–9246. 2014. View Article : Google Scholar

14 

Jiao WH, Xu TT, Zhao F, Gao H, Shi GH, Wang J, Hong LL, Yu HB, Li YS, Yang F and Lin HW: Dysifragilones A-C, unusual sesquiterpene aminoquinones and inhibitors of NO production from the South China sea sponge Dysidea fragilis. Eur J Org Chem. 2015:960–966. 2015. View Article : Google Scholar

15 

Denizot F and Lang R: Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 89:271–277. 1986. View Article : Google Scholar : PubMed/NCBI

16 

Ishihara T, Kohno K, Ushio S, Iwaki K, Ikeda M and Kurimoto M: Tryptanthrin inhibits nitric oxide and prostaglandin E(2) synthesis by murine macrophages. Eur J Pharmacol. 407:197–204. 2000. View Article : Google Scholar : PubMed/NCBI

17 

Wohlmuth H, Deseo MA, Brushett DJ, Thompson DR, Macfarlane G, Stevenson LM and Leach DN: Diarylheptanoid from Pleuranthodium racemigerum with in vitro prostaglandin E(2) inhibitory and cytotoxic activity. J Nat Prod. 73:743–746. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Zhao F, Xu H, He EQ, Jiang YT and Liu K: Inhibitory effects of sesquiterpenes from Saussurea lappa on the overproduction of nitric oxide and TNF-alpha release in LPS-activated macrophages. J Asian Nat Prod Res. 10:1045–1053. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Zhao F, Gao Z, Jiao W, Chen L, Chen L and Yao X: In vitro anti-inflammatory effects of bata-carboline alkaloids, isolated from Picrasma quassioiders, through inhibition of the iNOS pathway. Planta Med. 78:1906–1911. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Akram M, Kim KA, Kim ES, Shin YJ, Noh D, Kim E, Kim JH, Majid A, Chang SY, Kim JK and Bae ON: Selective inhibition of JAK2/STAT1 signaling and iNOS expression mediates the anti-inflammatory effects of coniferyl aldehyde. Chem Biol Interact. 256:102–110. 2016. View Article : Google Scholar : PubMed/NCBI

21 

Kim YS, Ahn CB and Je JY: Anti-inflammatory action of high molecular weight Mytilus edulis hydrolysates fraction in LPS-induced RAW264.7 macrophage via NF-κB and MAPK pathways. Food Chem. 202:9–14. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Kim SH, Kim J and Sharma RP: Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacol Res. 49:433–439. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Kaminska B: MAPK signaling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 1754:253–262. 2005. View Article : Google Scholar : PubMed/NCBI

24 

Rao KM: MAP kinase activation in macrophages. J Leukoc Biol. 69:3–10. 2001.PubMed/NCBI

25 

Valledor AF, Comalada M, Santamaría-Babi LF, Lloberas J and Celada A: Macrophage proinflammatory activation and deactivation: A question of balance. Adv Immunol. 108:1–20. 2010. View Article : Google Scholar : PubMed/NCBI

26 

Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008. View Article : Google Scholar : PubMed/NCBI

27 

Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI

28 

Libby P, Ridker PM and Maseri A: Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002. View Article : Google Scholar : PubMed/NCBI

29 

Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 352:1685–1695. 2005. View Article : Google Scholar : PubMed/NCBI

30 

Ignatova GL, Volchegorskii IA, Volkova EG and Kolesnikov OL: Intensity of lipid peroxidation: Indicator of inflammation severity in chronic bronchitis. B Exp Biol Med. 124:800–801. 1997. View Article : Google Scholar

31 

Hoogendijk AJ, Roelofs J, van Lieshout M, Blok DC, Poll TVD and Wieland CW: Cyclin-dependent kinase inhibitor r-roscovitine reduces lipoteichoic acid lung inflammation and improves the resolution of antibiotic-treated Streptococcus Pneuumoniae pneumonia. Crit Care. 13 Suppl 4:S392009. View Article : Google Scholar

32 

Wellen KE and Hotamisligil GS: Inflammation, stress and diabetes. J Clin Invest. 115:1111–1119. 2005. View Article : Google Scholar : PubMed/NCBI

33 

Liu J, Tang J, Zuo Y, Yu Y, Luo P, Yao X, Dong Y, Wang P, Liu L and Zhou H: Stauntoside B inhibits macrophage activation by inhibiting NF-κB and ERK MAPK signaling. Pharmacol Res. 111:303–315. 2016. View Article : Google Scholar : PubMed/NCBI

34 

Butterfield TA, Best TM and Merrick MA: The dual roles of neutrophils and macrophages in inflammation: A critical balance between tissue damage and repair. J Athl Train. 41:457–465. 2006.PubMed/NCBI

35 

Fitzpatrick JK and Downer EJ: Toll-like receptor signaling as a cannabinoid target in Multiple Sclerosis. Neuropharmacology. 113:618–626. 2017. View Article : Google Scholar : PubMed/NCBI

36 

Melander RJ, Liu HB, Stephens MD, Bewley CA and Melander C: Marine sponge alkaloids as a source of anti-bacterial adjuvants. Bioorg Med Chem Lett. 26:5863–5866. 2016. View Article : Google Scholar : PubMed/NCBI

37 

Nishimura S, Matsunaga S, Yoshida M, Hirota H, Yokoyama S and Fusetani N: 13-Deoxytedanolide, a marine sponge-derived antitumor macrolide, binds to the 60S large ribosomal subunit. Bioorg Med Chem. 13:449–454. 2005. View Article : Google Scholar : PubMed/NCBI

38 

EI-Hossary EM, Cheng C, Hamed MM, El-Sayed Hamed AN, Ohisen K, Hentschel U and Abdelmohsen UR: Antifungal potential of marine natural products. Eur J Med Chem. 126:631–651. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Mayer AM and Hamann MT: Marine pharmacology in 2000: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action. Mar Biotechnol (NY). 6:37–52. 2004. View Article : Google Scholar : PubMed/NCBI

40 

Laroux FS, Pavlick KP, Hines IN, Kawachi S, Harada H, Bharwani S, Hoffman JM and Grisham MB: Role of nitric oxide in inflammation. Acta Physiol Scand. 173:113–118. 2001. View Article : Google Scholar : PubMed/NCBI

41 

Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP and Versteeg HH: Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol. 36:1187–1205. 2004. View Article : Google Scholar : PubMed/NCBI

42 

Kang CH, Han SH, Koo JR and So JS: Chrysanthemum zawadskii var. latilobum extract inhibits the production of nitric oxide and PGE2 through inducible nitric oxide synthase (iNOS) and cyclooxygenase-2(COX-2) in RAW 264.7 cells. Biotechnol Bioproc Eng. 18:501–506. 2013. View Article : Google Scholar

43 

Lee JK, Sayer BC, Chun KS, Lao HC, Shipley-phillips JK, Bonner JC and Langenbach R: Multi-walled carbon nanotubes induce COX-2 and iNOS expression via MAP kinase-dependent and -independent mechanisms in mouse RAW264.7 macrophages. Part Fibre Toxicol. 9:142012. View Article : Google Scholar : PubMed/NCBI

44 

Fujiwara N and Kobayashi K: Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 4:281–286. 2005. View Article : Google Scholar : PubMed/NCBI

45 

Karin M and Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol. 3:221–227. 2002. View Article : Google Scholar : PubMed/NCBI

46 

Ham YM, Ko YJ, Song SM, Kim J, Kim KN, Yun JH, Cho JH, Ahn G and Yoon WJ: Anti-inflammatory effect of litsenolide B2 isolated from Litsea japonica fruit via suppressing NF-κB and MAPK pathways in LPS-induced RAW264.7 cells. J Funct Foods. 13:80–88. 2015. View Article : Google Scholar

47 

Wu J, Xue X, Wu Z, Zhao HL, Cao HM, Sun DQ, Wang RM, Sun J, Liu Y and Guo RC: Anti-tumor effect of paeonol via regulating NF-κB, AKT and MAPKs activation: A quick review. Biomed Pre Nutr. 4:9–14. 2014. View Article : Google Scholar

48 

Liu Y, Shepherd EG and Nelin LD: MAPK phosphatases-regulating the immune response. Nat Rev Immunol. 7:202–212. 2007. View Article : Google Scholar : PubMed/NCBI

49 

Liu SJ, Shi Y, Liu C, Zhang M, Zuo ZC, Zeng CJ, Zhou GB, Xian H and Song TZ: The upregulation of pro-inflammatory cytokines in the rabbit uterus under the lipopolysaccaride-induced reversible immunoresponse state. Anim Reprod Sci. 176:70–77. 2017. View Article : Google Scholar : PubMed/NCBI

50 

Arthur JS and Ley SC: Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 13:679–692. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li H, Zhang Q, Jin X, Zou X, Wang Y, Hao D, Fu F, Jiao W, Zhang C, Lin H, Lin H, et al: Dysifragilone A inhibits LPS‑induced RAW264.7 macrophage activation by blocking the p38 MAPK signaling pathway. Mol Med Rep 17: 674-682, 2018.
APA
Li, H., Zhang, Q., Jin, X., Zou, X., Wang, Y., Hao, D. ... Zhao, F. (2018). Dysifragilone A inhibits LPS‑induced RAW264.7 macrophage activation by blocking the p38 MAPK signaling pathway. Molecular Medicine Reports, 17, 674-682. https://doi.org/10.3892/mmr.2017.7884
MLA
Li, H., Zhang, Q., Jin, X., Zou, X., Wang, Y., Hao, D., Fu, F., Jiao, W., Zhang, C., Lin, H., Matsuzaki, K., Zhao, F."Dysifragilone A inhibits LPS‑induced RAW264.7 macrophage activation by blocking the p38 MAPK signaling pathway". Molecular Medicine Reports 17.1 (2018): 674-682.
Chicago
Li, H., Zhang, Q., Jin, X., Zou, X., Wang, Y., Hao, D., Fu, F., Jiao, W., Zhang, C., Lin, H., Matsuzaki, K., Zhao, F."Dysifragilone A inhibits LPS‑induced RAW264.7 macrophage activation by blocking the p38 MAPK signaling pathway". Molecular Medicine Reports 17, no. 1 (2018): 674-682. https://doi.org/10.3892/mmr.2017.7884
Copy and paste a formatted citation
x
Spandidos Publications style
Li H, Zhang Q, Jin X, Zou X, Wang Y, Hao D, Fu F, Jiao W, Zhang C, Lin H, Lin H, et al: Dysifragilone A inhibits LPS‑induced RAW264.7 macrophage activation by blocking the p38 MAPK signaling pathway. Mol Med Rep 17: 674-682, 2018.
APA
Li, H., Zhang, Q., Jin, X., Zou, X., Wang, Y., Hao, D. ... Zhao, F. (2018). Dysifragilone A inhibits LPS‑induced RAW264.7 macrophage activation by blocking the p38 MAPK signaling pathway. Molecular Medicine Reports, 17, 674-682. https://doi.org/10.3892/mmr.2017.7884
MLA
Li, H., Zhang, Q., Jin, X., Zou, X., Wang, Y., Hao, D., Fu, F., Jiao, W., Zhang, C., Lin, H., Matsuzaki, K., Zhao, F."Dysifragilone A inhibits LPS‑induced RAW264.7 macrophage activation by blocking the p38 MAPK signaling pathway". Molecular Medicine Reports 17.1 (2018): 674-682.
Chicago
Li, H., Zhang, Q., Jin, X., Zou, X., Wang, Y., Hao, D., Fu, F., Jiao, W., Zhang, C., Lin, H., Matsuzaki, K., Zhao, F."Dysifragilone A inhibits LPS‑induced RAW264.7 macrophage activation by blocking the p38 MAPK signaling pathway". Molecular Medicine Reports 17, no. 1 (2018): 674-682. https://doi.org/10.3892/mmr.2017.7884
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team